Sepsis and Hemodynamic Support in September 15, 2017 Carleen Risaliti

Similar documents
Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

John Park, MD Assistant Professor of Medicine

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

Sepsis Management: Past, Present, and Future

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa

Vasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Update in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D.

UPDATES IN SEPSIS MANAGEMENT Shannon Fry, Pharm.D. Critical Care Pharmacy Specialist St. Joseph Medical Center

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Diagnosis and Management of Sepsis. Disclosures

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

Actualités de la prise en charge hémodynamique initiale Daniel De Backer

6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts,

Case year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018

Should we use steroids in sepsis? J.G. van der Hoeven

Sepsis. From EMS to ER to ICU. What we need to be doing

Should Roids Be the Rage in Septic Shock? Lauren Powell, MSN, RN, CCRN, AGACNP-BC CHI Baylor St. Luke s Medical Center, Houston, TX

Sepsis: Identification and Management in an Acute Care Setting

Updates in Sepsis 2017

Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL

Nothing to disclose 9/25/2017

9/25/2017. Nothing to disclose

OHSU. Update in Sepsis

Troubleshooting Audio

SEPSIS 2015 DISCLOSURES FINANCIAL DISCLOSURES 9/1/2015. William M. Johnson, MD Nebraska Pulmonary Specialties. William Johnson

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

The Management of Septic Shock

Inflammation. Sepsis Ladder

BC Sepsis Network Emergency Department Sepsis Guidelines

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Sepsis and septic shock: can we win the battle against this hidden crisis?

VOLUME RESPONSIVENESS IS DIFFERENT FROM NEED FOR FLUIDS BLOOD PRESSURE TARGETS IN SEPSIS

CORTICOSTEROID USE IN SEPTIC SHOCK THE ONGOING DEBATE DIEM HO, PHARMD PGY1 PHARMACY RESIDENT VALLEY BAPTIST MEDICAL CENTER BROWNSVILLE

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Sepsis Review. Angela Craig APN,MS,CCNS Clinical Nurse Specialist Intensive Care Unit Cookeville Regional Medical Center

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill

Surviving Sepsis Campaign

Billion

Where did it all begin?

towards early goal directed therapy

Ralph Palumbo, MD, FCCP

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

Early Goal-Directed Therapy

Early-goal-directed therapy and protocolised treatment in septic shock

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

Sepsis Management Update 2014

SEPSIS UPDATE WHY DO WE NEED A CORE MEASURE CHAD M. KOVALA DO, FACOEP, FACEP

Fluid balance and clinically relevant outcomes

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us?

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

Beyond the Golden Hour: Caring for the ICU Boarder

Sepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand

Dr. İsa KILIÇASLAN Gazi University School of Medicine

Core Measures SEPSIS UPDATES

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Caring For the ICU Boarder. Kami M. Hu, MD Depts of Emergency & Internal Medicine University of Maryland SOM

Sepsis Wave II. Fluid and Pressors Management Challenging Cases and Exceptions

The 2016 Surviving Sepsis Guidelines have arrived, a

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

EARLY GOAL DIRECTED THERAPY : seminaires iris. Etat des lieux en Daniel De Backer

Critical Care Medicine Update for Non-Intensivists 2015

No conflicts of interest

Rounds in the ICU. Eran Segal, MD Director General ICU Sheba Medical Center

Purist? or Pragmatist? Assessment & Management of ICU Volume Status

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

4/4/2014. Of patients diagnosed with sepsis 50% will develop severe sepsis 25% will develop shock. SIRS Sepsis Severe Septic Sepsis Shock.

AnnMarie Papa, DNP,RN,CEN,NE-BC,FAEN, FAAN Clinical Director, Emergency, Medical & Observation Nursing Hospital of the University of Pennsylvania

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Objectives. Outline. Sepsis Incidence and Outcomes. Definitions

Sepsis: Update on Diagnosis, Evaluation and Management

Sepsis Combine experience and Evidence. Eran Segal, MD Director General ICU, Sheba Medical Center, Israel

What works in sepsis. Topics. EGDT: Severe Sepsis/ Shock. Sepsis

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

Sepsis Wave II Webinar Series. Sepsis Reassessment

Managing Patients with Sepsis

Resuscitation Symposium Resuscitation Literature Update. Abdullah Al Reesi, MD, MSc, FACEP, FRCPC Sr. Consultant and HoD SQUH

Why does it matter? Sepsis

Utilizing Vasopressors:

Epidemiology of Severe Sepsis

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

What is sepsis? RECOGNITION. Sepsis I Know It When I See It 9/21/2017

Steps to Success in Sepsis ASHNHA Quality Webinar. Maryanne Whitney, RN, CNS, MSN Improvement Advisor, Cynosure Health

Vasopressors for shock

THE CRITICALLY ILL OLDER PERSON WITH: SEPTIC SHOCK

Taiwan Crit. Care Med.2009;10: C 1. CVP 8~12 mmhg 2. MAP 65 mmhg 1. 1B

Pediatric Sepsis Treatment:

Management of Severe Sepsis:

Dilemmas in Septic Shock

Bedside assessment of fluid status

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.

Practical. Septic shock resuscitation ไชยร ตน เพ มพ ก ล พบ. ภาคว ชาอาย รศาสตร คณะแพทยศาสตร ศ ร ราชพยาบาล

Transcription:

Sepsis and Hemodynamic Support in 2017 September 15, 2017 Carleen Risaliti Objectives Review fluid resuscitation guidelines in septic shock Discuss volume assessment v. fluid responsiveness Evaluate pros and cons of various vasopressor options Discuss utilizing corticosteroids in septic shock Understand when to transfuse blood products in septic shock 2 1

65 yo man with a history of HTN, CAD, ischemic cardiomyopathy (EF 45%) admitted with new onset AF with RVR, now s/p TEE and cardioversion Since admission, he has increasing cough and shortness of breath Temp 102.2; HR 118; BP 78/44; RR 24; O2 sat 89% on 6L NC WBC 16 CXR with new RML consolidation 3 You order a vancomycin, zosyn due to concern for HCAP What should you do next? A. Give 2L IVF B. Start norepinephrine 0.05mcg/kg/min C. Insert right IJ CVC to assess CVP D. Arrange for transfer to the MICU 4 2

You order a vancomycin, zosyn due to concern for HCAP What should you do next? A. Give 2L IVF B. Start norepinephrine 0.05mcg/kg/min C. Insert right IJ CVC to assess CVP D. Arrange for transfer to the MICU 5 Early Goal-Directed Therapy 6 Rivers, N Engl J Med, 2001 3

PROCESS PROMISE ARISE Description 31 EDs in the US; 2014 56 hospitals in England; 2015 51 centers (Austrailia, New Zealand); 2014 Study groups Three groups: EGDT (Rivers protocol) v. EGDT (no CVC, ionotropes, transfusions) v. usual care Two groups: EGDT (6hrs) v. usual care Two groups: EGDT v. usual care Primary outcome No difference in 60-day mortality No difference in 90- day mortality No difference in 90-day mortality, in-hospital mortality or LOS Secondary outcomes No difference in 90- day mortality, 1- year mortality or need for organ support EGDT group had increased costs Patients in the EGDT group received more IVF in the first 6 hrs 7 IVF Resuscitation Treatment and resuscitation should begin immediately Administer IV crystalloids at rate of at least 30cc/kg within the first 3 hours Additional fluids should be given based on reassessment of hemodynamic status Utilize dynamic (versus static) variables to predict fluid responsiveness 8 4

Fluid Therapy Crystalloids are the fluid of choice for initial resuscitation Balanced crystalloids preferred over normal saline Hydroxyethyl starches should not be used for resuscitation 9 Assessment Tool Marker Notes STATIC Volume assessment CVP (PAOP, LVEDP, IVC diameter) DYNAMIC Pulse pressure variation (PPV) Passive leg raising test (PLR) Change in IVC diameter Mini fluid challenge Goal > 8-12 to be considered volume replete > 10-15% predictive of fluid responsiveness > 10% in CO predictive of fluid responsiveness 12-18% variation predicts 10% increase in CO > 10% in subaortic velocity time interval (measured by echo) predictive of volume responsiveness Fluid responsiveness No spontaneous respirations; Vt 8-12cc/kg; no arrhythmias 10 5

Is there such a thing as too much fluid? 11 Boyd JH et al, Crit Care Med, 2011 You administer 2L of LR (~30cc/kg) but the patient remains hypotensive (MAP 52) Bedside U/S reveals global hypokinesis, depressed EF What should you do next? A. Give additional 2L IVF B. Start norepinephrine 0.05mcg/kg/min and titrate for MAP > 65 C. Start dopamine 5mg and titrate for MAP > 65 D. Arrange for transfer to the MICU 12 6

You administer 2L of LR (~30cc/kg) but the patient remains hypotensive (MAP 52) Bedside U/S reveals global hypokinesis, depressed EF What should you do next? A. Give additional 2L IVF B. Start norepinephrine 0.05mcg/kg/min and titrate for MAP > 65 C. Start dopamine 5mg and titrate for MAP > 65 D. Arrange for transfer to the MICU 13 Vasopressors 14 De Backer (SOAPII), N Engl J Med, 2010 7

Vasopressors 15 De Backer (SOAPII), N Engl J Med, 2010 VASST trial No significant difference in 28-day mortality or 90-day mortality Addition of vasopressin allowed decrease in norepinephrine while maintaining MAP 16 Russell, N Engl J Med, 2008 8

Vasopressors First choice vasopressor is norepinephrine Vasopressin (up to 0.03 U/min) or epinephrine can be added to norepinephrine to increase the MAP or decrease norepinephrine dosages Dopamine should only be used in highly selected patients (weak recommendation, low quality of evidence) Dobutamine should be used in patient with persistent hypotension despite fluid loading and use of vasopressors (weak recommendation, low quality of evidence) 17 The patient is no longer responsive to IVF and his oxygenation continued to worsen requiring in intubation He is currently on norepinephrine 0.5mcg/kg/min and vasopressin 0.03 The medical student asks you whether you should add stress dose steroids and you respond by saying 18 9

Should we give steroids? A. Yes, but let s complete an ACTH stim test first B. Sure, there isn t a lot of evidence for them, but it (likely) won t hurt C. Nope, there s no evidence for steroids in septic shock D. Umm, let s arrange transfer to the MICU 19 Should we give steroids? A. Yes, but let s complete an ACTH stim test first B. Sure, there isn t a lot of evidence for them, but it (likely) won t hurt C. Nope, there s no evidence for steroids in septic shock D. Umm, let s arrange transfer to the MICU 20 10

Corticosteroids in septic shock 21 Sprung, N Engl J Med, 2008 Corticosteroids in septic shock 22 Annane, JAMA, 2002 11

What about steroids? More trials needed Emphasis should be placed ensuring adequate fluid resuscitation and vasopressor support If unable to achieve hemodynamic support with fluids and vasopressors, corticosteroids can be added Steroid dose is hydrocortisone 200mg IV (weak recommendation; low quality evidence) 23 And Blood Products? 24 Holst, N Engl J Med, 2014 12

And Blood Products? 25 Holst, N Engl J Med, 2014 Transfusion Goals in Sepsis Transfuse PRBCs when hemoglobin is < 7 g/dl Transfuse platelets when < 10,000/mm 3 in the absence of bleeding and < 20,000/mm 3 if the patient has a risk of bleeding (weak recommendation, very low quality of evidence) Do not transfuse FFP in the absence of bleeding or planned invasive procedure (weak recommendation, very low quality of evidence) 26 13

Hemodynamic Support in Sepsis Identify sepsis Start IV crystalloids at 30cc/kg within first 3 hrs Use norepinephrine as first-choice vasopressor Use vasopressin or epinephrine to raise MAP/decrease norepinephrine dosage Start antibiotics Ensure adequate source control Consider steroids 27 References Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med, 2017;45(3): 486-552. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):1368-77. The ProCESS investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014;370(18):1683-93. Mouncey PR, Osborn TM, Power GS et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015;372(14):1301-11. The ARISE investigators and the ANZICS Clinal Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014;371(16):496-506. Boyd JH, Forbes J, Nakada T, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011;39:259-265. De Backer D, Biston P, Devriendt J et al. Comparison of dopamine and norepinephrine in treatment of shock. N Engl J Med 2010;362(9):779-89. Russell JA, Walley KR, Singer J et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358(9):877-87. 28 14

References Sprung CL, Annane D, Keh D et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358(2):111-24. Annane D, Sebille V, Charpenteir C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone in patients with septic shock. JAMA 2002;288(7):862-71. Volbeda M, Wetterslev J, Glund C, Zijlstra JG, van der Horst ICC, Keus F. Glucocorticoids for sepsis: systemic review with meta-analysis and trial sequential analysis. Intensive Care Med 2015;41:1220-34. Holst LB, Haase N, Wetterslev J et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014;371(15):1381-91. 29 15